| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,181 | 14,535 | 14,247 | 15,025 | | Cost of Revenue | 7,050 | 5,983 | 5,937 | 7,039 | | | Gross Profit | 8,131 | 8,552 | 8,310 | 7,986 | | | Operating Expenses | | Research Development | 4,349 | 4,292 | 5,643 | 7,633 | | Selling General and Administrative | 4,297 | 4,608 | 4,983 | 5,182 | | Non Recurring | 150 | (35) | (6,157) | 3,581 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (634) | (313) | 3,841 | (8,410) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (415) | (697) | 537 | 4,726 | | Earnings Before Interest And Taxes | (1,080) | (1,010) | 4,378 | (3,684) | | Interest Expense | 206 | 202 | 199 | 471 | | Income Before Tax | (1,286) | (1,212) | 4,179 | (4,155) | | Income Tax Expense | 211 | 108 | 163 | 121 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,497) | (1,320) | 4,016 | (4,276) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,497) | (1,320) | 4,016 | (4,276) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,497) | ($1,320) | $4,016 | ($4,276) |
|
0.56% Nasdaq 
Income Statement
